{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:01:57Z","timestamp":1790676117048,"version":"4.1.0"},"reference-count":166,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG SFB\/TRR296, CRC1382, Ta434\/3-1, Ta434\/5-1"],"award-info":[{"award-number":["DFG SFB\/TRR296, CRC1382, Ta434\/3-1, Ta434\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Liver fibrosis is a chronic, highly prevalent disease that may progress to cirrhosis and substantially increases the risk for development of hepatocellular carcinoma (HCC). Fibrotic livers are characterized by an inflammatory microenvironment that is composed of various immunologically active cells, including liver-resident populations (e.g., Kupffer cells, hepatic stellate cells and sinusoidal endothelium) and infiltrating leukocytes (e.g., monocytes, monocyte-derived macrophages, neutrophils and lymphocytes). While inflammatory injury drives both fibrogenesis and carcinogenesis, the tolerogenic microenvironment of the liver conveys immunosuppressive effects that encourage tumor growth. An insufficient crosstalk between dendritic cells (DCs), the professional antigen presenting cells, and T cells, the efficient anti-tumor effector cells, is one of the main mechanisms of HCC tumor tolerance. The meticulous analysis of patient samples and mouse models of fibrosis-HCC provided in-depth insights into molecular mechanisms of immune interactions in liver cancer. The therapeutic modulation of this multifaceted immunological response, e.g., by inhibiting immune checkpoint molecules, in situ vaccination, oncolytic viruses or combinations thereof, is a rapidly evolving field that holds the potential to improve the outcome of patients with HCC. This review aims to highlight the current understanding of DC\u2013T cell interactions in fibrogenesis and hepatocarcinogenesis and to illustrate the potentials and pitfalls of therapeutic clinical translation.<\/jats:p>","DOI":"10.3390\/ijms21197378","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T10:46:17Z","timestamp":1601981177000},"page":"7378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-7707","authenticated-orcid":false,"given":"Isabella","family":"Lurje","sequence":"first","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0557-3927","authenticated-orcid":false,"given":"Linda","family":"Hammerich","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charit\u00e9 University Medicine Berlin, 13353 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri981","article-title":"Hepatic T cells and liver tolerance","volume":"3","author":"Crispe","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2014From homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1111\/j.1440-1746.2007.05274.x","article-title":"Innate immunity and alcoholic liver fibrosis","volume":"23","author":"Jeong","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.03.035","article-title":"Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells","volume":"389","author":"Mitchell","year":"2009","journal-title":"Virology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Finucane","year":"2012","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2014.08.007","article-title":"Hepatocellular carcinoma epidemiology","volume":"28","author":"Bosetti","year":"2014","journal-title":"Best Pr. Res. Clin. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000343828","article-title":"Treatment of hepatocellular carcinoma: A systematic review","volume":"1","author":"Lin","year":"2012","journal-title":"Liver Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lurje, I., Czigany, Z., Bednarsch, J., Roderburg, C., Isfort, P., Neumann, U.P., and Lurje, G. (2019). Treatment Strategies for Hepatocellular Carcinoma \u2013 a Multidisciplinary Approach. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061465"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","article-title":"Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma","volume":"24","author":"Schwartz","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in Advanced Hepatocellular Carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"Sangro","year":"2017","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2019.05.014","article-title":"Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis","volume":"71","author":"Yau","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","article-title":"Cold Tumors: A Therapeutic Challenge for Immunotherapy","volume":"10","author":"Bonaventura","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a Novel Cell Type in Peripheral Lymphoid Organs of Mice","volume":"137","author":"Steinman","year":"1973","journal-title":"J. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells: Specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Steinman","year":"2003","journal-title":"Ann. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.imbio.2006.05.025","article-title":"Migratory fate and differentiation of blood monocyte subsets","volume":"211","author":"Tacke","year":"2006","journal-title":"Immunobiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4049\/jimmunol.0803404","article-title":"Human Liver Dendritic Cells Promote T Cell Hyporesponsiveness","volume":"182","author":"Bamboat","year":"2009","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"ref_27","first-page":"336","article-title":"Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation","volume":"38","author":"Segura","year":"2013","journal-title":"Immunology"},{"key":"ref_28","first-page":"573","article-title":"Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells","volume":"51","author":"Dutertre","year":"2019","journal-title":"Immunology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic Cell Populations With Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_30","first-page":"260","article-title":"Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions","volume":"6","author":"Manh","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.194.8.1171","article-title":"Cd11c+B220+Gr-1+ Cells in Mouse Lymph Nodes and Spleen Display Characteristics of Plasmacytoid Dendritic Cells","volume":"194","author":"Nakano","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_32","first-page":"481","article-title":"Antigen Crosspresentation by Human Plasmacytoid Dendritic Cells","volume":"27","author":"Hoeffel","year":"2007","journal-title":"Immunology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cell.2010.09.039","article-title":"Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN\/CD209+ Dendritic Cells for Immune T Cell Areas","volume":"143","author":"Cheong","year":"2010","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(98)80206-7","article-title":"Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes","volume":"28","author":"Norris","year":"1998","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/gast.1996.v110.pm8566600","article-title":"Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium","volume":"110","author":"McNab","year":"1996","journal-title":"Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1084\/jem.183.4.1865","article-title":"A life stage of particle-laden rat dendritic cells in vivo: Their terminal division, active phagocytosis, and translocation from the liver to the draining lymph","volume":"183","author":"Matsuno","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1053\/gast.2001.29594","article-title":"Kupffer cell\u2013mediated recruitment of rat dendritic cells to the liver: Roles of N-acetylgalactosamine\u2013specific sugar receptors","volume":"121","author":"Uwatoku","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/cmi.2015.109","article-title":"Presentation of hepatocellular antigens","volume":"13","author":"Grakoui","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0168-8278(95)80433-1","article-title":"Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge","volume":"22","author":"Knoll","year":"1995","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1182\/blood.V99.7.2468","article-title":"CD4+ and CD8+ anergic T cells induced by interleukin-10\u2013treated human dendritic cells display antigen-specific suppressor activity","volume":"99","author":"Steinbrink","year":"2002","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood-2008-12-195073","article-title":"Interferon-\u03b3\u2013triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells","volume":"114","author":"Hainz","year":"2009","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Pallotta","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatology"},{"key":"ref_46","first-page":"85","article-title":"The Etiology, Diagnosis and Prevention of Liver Cirrhosis","volume":"110","author":"Wiegand","year":"2013","journal-title":"Dtsch. Aerzteblatt Online"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver Macrophages: Old Dogmas and New Insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep.24621","article-title":"Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression","volume":"55","author":"Jiao","year":"2011","journal-title":"Hepatoloy"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2013.05.033","article-title":"Dendritic cells in liver injury and fibrosis: Shortcomings and promises","volume":"59","author":"Schuppan","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Sutti, S., Bruzz\u00ec, S., Heymann, F., Liepelt, A., Krenkel, O., Toscani, A., Ramavath, N.N., Cotella, D., Albano, E., and Tacke, F. (2019). CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation. Cells, 8.","DOI":"10.3390\/cells8091099"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/CS20150053","article-title":"CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis","volume":"129","author":"Sutti","year":"2015","journal-title":"Clin. Sci."},{"key":"ref_55","first-page":"3213","article-title":"In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha","volume":"119","author":"Connolly","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/187152809789352230","article-title":"Monocytes and macrophages as cellular targets in liver fibrosis","volume":"8","author":"Heymann","year":"2009","journal-title":"Inflamm. Allergy-Drug Targets"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10456-013-9382-5","article-title":"Dendritic cells regulate angiogenesis associated with liver fibrogenesis","volume":"17","author":"Blois","year":"2013","journal-title":"Angiogenesis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1136\/gutjnl-2013-306294","article-title":"CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis","volume":"63","author":"Ehling","year":"2014","journal-title":"Gut"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcmgh.2018.10.007","article-title":"The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers","volume":"7","author":"Bartneck","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbadis.2012.09.008","article-title":"Natural killer and natural killer T cells in liver fibrosis","volume":"1832","author":"Gao","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zhang, M., and Zhang, S. (2020). T Cells in Fibrosis and Fibrotic Diseases. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01142"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: An emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the Liver by Intravascular Effector CD8 + T Cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Murata, Y., Kawashima, K., Sheikh, K., Tanaka, Y., and Isogawa, M. (2018). Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8+ T Cell Responses. J. Virol., 92.","DOI":"10.1128\/JVI.00920-18"},{"key":"ref_67","first-page":"200","article-title":"Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming","volume":"574","author":"Cilenti","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Imm."},{"key":"ref_69","first-page":"145","article-title":"Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis","volume":"45","author":"Gieseck","year":"2016","journal-title":"Immunology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.4049\/jimmunol.164.12.6406","article-title":"IL-10 and the Dangers of Immune Polarization: Excessive Type 1 and Type 2 Cytokine Responses Induce Distinct Forms of Lethal Immunopathology in Murine Schistosomiasis","volume":"164","author":"Hoffmann","year":"2000","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI7325","article-title":"An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2\u2013dominated inflammatory response","volume":"104","author":"Chiaramonte","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J. Exp Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Fabre, T., Molina, M.F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., and Shoukry, N.H. (2018). Type 3 cytokines IL-17A and IL-22 drive TGF-\u03b2\u2013dependent liver fibrosis. Sci. Immunol., 3.","DOI":"10.1126\/sciimmunol.aar7754"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2008","journal-title":"Hepatology"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Li, J., Qiu, S.-J., She, W.-M., Wang, F.-P., Gao, H., Li, L., Tu, C.-T., Wang, J.-Y., Shen, X.-Z., and Jiang, W. (2012). Significance of the Balance between Regulatory T (Treg) and T Helper 17 (Th17) Cells during Hepatitis B Virus Related Liver Fibrosis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039307"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/345803","article-title":"Role of IL-17 and Th17 Cells in Liver Diseases","volume":"2011","author":"Hammerich","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T Cells in Autoimmmunity","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.23043","article-title":"Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver","volume":"50","author":"Breous","year":"2009","journal-title":"Hepatology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.trsl.2015.10.008","article-title":"Persistence of cirrhosis is maintained by intrahepatic regulatory T cells that inhibit fibrosis resolution by regulating the balance of tissue inhibitors of metalloproteinases and matrix metalloproteinases","volume":"169","author":"Zhang","year":"2016","journal-title":"Transl. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.12659\/MSM.899725","article-title":"Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice","volume":"23","author":"Zhang","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2019.01.247","article-title":"CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell\u2013Dependent Control of Senescence","volume":"156","author":"Mossanen","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/hep.26405","article-title":"From NAFLD to NASH to fibrosis to HCC: Role of dendritic cell populations in the liver","volume":"58","author":"Tacke","year":"2013","journal-title":"Hepatology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jhep.2007.03.024","article-title":"Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function","volume":"47","author":"Lai","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","article-title":"Innate immune cells in cirrhosis","volume":"73","author":"Bernsmeier","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1530-0277.1996.tb01700.x","article-title":"Distribution of Peripheral Blood Lymphoid Subsets in Alcoholic Liver Cirrhosis: Influence of Ethanol Intake","volume":"20","author":"Laso","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4049\/jimmunol.179.1.13","article-title":"Human IgM+CD27+B Cells: Memory B Cells or \u201cMemory\u201d B Cells?","volume":"179","author":"Tangye","year":"2007","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/hep.24689","article-title":"Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population","volume":"55","author":"Doi","year":"2012","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/509580","article-title":"The Impact of Cirrhosis on CD4+ T Cell Counts in HIV-Seronegative Patients","volume":"44","author":"McGovern","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.05.042","article-title":"Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis","volume":"59","author":"Lario","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Veglia, F., Tyurin, V.A., Mohammadyani, D., Blasi, M., Duperret, E.K., Donthireddy, L., Hashimoto, A., Kapralov, A., Amoscato, A., and Angelini, R. (2017). Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat. Commun., 8.","DOI":"10.1038\/s41467-017-02186-9"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized lipids block antigen cross-presentation by dendritic cells in cancer","volume":"192","author":"Ramakrishnan","year":"2014","journal-title":"J. Imm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/icb.2013.38","article-title":"Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells","volume":"91","author":"Harimoto","year":"2013","journal-title":"Imm. Cell Bio."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fimmu.2013.00438","article-title":"Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity","volume":"4","author":"Dudek","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V100.1.174","article-title":"Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans","volume":"100","author":"Dhodapkar","year":"2002","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ccr.2012.01.008","article-title":"Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells","volume":"21","author":"Engelhardt","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.cji.0000158854.15664.c2","article-title":"Mature Dendritic Cells Induce Tumor-Specific Type 1 Regulatory T Cells","volume":"28","author":"Lundqvist","year":"2005","journal-title":"J. Immunother."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Pedroza-Gonzalez, A., Zhou, G., Vargas-Mendez, E., Boor, P.P., Mancham, S., Verhoef, C., Polak, W.G., Gr\u00fcnhagen, D., Pan, Q., and La Janssen, H. (2015). Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors. OncoImmunology, 4.","DOI":"10.1080\/2162402X.2015.1008355"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","article-title":"Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas","volume":"153","author":"Zhou","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","article-title":"Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis","volume":"6","author":"Yang","year":"2004","journal-title":"Cancer Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4291\/wjgp.v6.i3.43","article-title":"Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis","volume":"6","author":"Hammerich","year":"2015","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00262-011-1143-y","article-title":"Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines","volume":"61","author":"Poschke","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","article-title":"Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine","volume":"70","author":"Srivastava","year":"2009","journal-title":"Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4049\/jimmunol.168.2.689","article-title":"Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism","volume":"168","author":"Mazzoni","year":"2002","journal-title":"J. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1200\/JCO.2006.09.4565","article-title":"Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection","volume":"25","author":"Gao","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Chen, K.-J., Lin, S.-Z., Zhou, L., Xie, H.-Y., Zhou, W.-H., Taki-Eldin, A., and Zheng, S.-S. (2011). Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024671"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/hep.26731","article-title":"Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma","volume":"59","author":"Flecken","year":"2014","journal-title":"Hepatology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.26694","article-title":"Human CD14+CTLA-4+regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma","volume":"59","author":"Han","year":"2013","journal-title":"Hepatology"},{"key":"ref_118","first-page":"86","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nat. Cell Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"ref_120","first-page":"183","article-title":"Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer","volume":"57","author":"Verhoef","year":"2012","journal-title":"Hepatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccr.2006.06.016","article-title":"Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment","volume":"10","author":"Budhu","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.18632\/oncotarget.27146","article-title":"Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma","volume":"10","author":"Tauber","year":"2019","journal-title":"Oncotarget"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1396-4","article-title":"From bench to bed: The tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma","volume":"38","author":"Fu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/0008-5472.CAN-15-0977","article-title":"Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis","volume":"76","author":"Ye","year":"2016","journal-title":"Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Li, H., Deng, Y., Tai, Y., Zeng, K., Zhang, Y., Liu, W., Zhang, Q., and Yang, Y. (2018). Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis., 9.","DOI":"10.1038\/s41419-018-0458-4"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Li, Y., and Zhu, B. (2015). T-cell exhaustion in the tumor microenvironment. Cell Death Dis., 6.","DOI":"10.1038\/cddis.2015.162"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00535-014-0933-3","article-title":"Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy","volume":"50","author":"Umemoto","year":"2014","journal-title":"J. Gastroenterol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.25777","article-title":"Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jcyt.2018.06.002","article-title":"Effect of dendritic cell-based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis","volume":"20","author":"Chen","year":"2018","journal-title":"Cytotherapy"},{"key":"ref_130","unstructured":"AB, T. N. M. (2020, August 28). The Nobel Prize in Physiology or Medicine 2018. Available online: https:\/\/www.nobelprize.org\/prizes\/medicine\/2018\/summary\/."},{"key":"ref_131","first-page":"1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy","volume":"342","year":"2013","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/cncr.23086","article-title":"Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4)","volume":"110","author":"Hamid","year":"2007","journal-title":"Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the Treatment of Non\u2013Small-Cell Lung Cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/CCID.S120877","article-title":"Checkpoint inhibitors for malignant melanoma: A systematic review and meta-analysis","volume":"10","author":"Karlsson","year":"2017","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_136","unstructured":"Administration, U. S. F. a. D. (2020, August 28). FDA Grants Accelerated Approval to Nivolumab for HCC Previously Treated with Sorafenib, Available online: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-nivolumab-hcc-previously-treated-sorafenib."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00262-011-1172-6","article-title":"An immune-active tumor microenvironment favors clinical response to ipilimumab","volume":"61","author":"Ji","year":"2012","journal-title":"Cancer Imm. Immunothe."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, Activity, and Immune Correlates of Anti\u2013PD-1 Antibody in Cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1200\/JCO.2016.68.1478","article-title":"Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and\/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort","volume":"34","author":"Chow","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterol."},{"key":"ref_141","first-page":"4908","article-title":"Abstract 4908: Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells","volume":"76","author":"Cueto","year":"2016","journal-title":"Immunology"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Arlauckas, S.P., Garris, C.S., Kohler, R.H., Kitaoka, M., Cuccarese, M.F., Yang, K.S., Miller, M.A., Carlson, J.C., Freeman, G.J., and Anthony, R.M. (2017). In vivo imaging reveals a tumor-associated macrophage\u2013mediated resistance pathway in anti\u2013PD-1 therapy. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aal3604"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner","volume":"13","author":"Holmgaard","year":"2015","journal-title":"Cell Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma","volume":"24","author":"Gide","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.3748\/wjg.v25.i24.2977","article-title":"Immunotherapy for hepatocellular carcinoma: Current and future","volume":"25","author":"Johnston","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20012100","article-title":"Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells","volume":"195","author":"Schultz","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Rizell, M., Eilard, M.S., Andersson, M., Andersson, B., Karlsson-Parra, A., and Suenaert, P. (2019). Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00019"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijrobp.2012.06.020","article-title":"Radiation Therapy to Convert the Tumor Into an In Situ Vaccine","volume":"84","author":"Formenti","year":"2012","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","article-title":"Combination Immunotherapy of B16 Melanoma Using Anti\u2013Cytotoxic T Lymphocyte\u2013Associated Antigen 4 (Ctla-4) and Granulocyte\/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation","volume":"190","author":"Hurwitz","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41591-019-0410-x","article-title":"Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination","volume":"25","author":"Hammerich","year":"2019","journal-title":"Nat. Med."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Moehler, M., Heo, J., Lee, H., Tak, W., Chao, Y., Paik, S., Yim, H., Byun, K., Baron, A., and Ungerechts, G. (2019). Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: A randomized multicenter Phase IIb trial (TRAVERSE). OncoImmunology, 8.","DOI":"10.1080\/2162402X.2019.1615817"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrc2545","article-title":"Targeted and armed oncolytic poxviruses: A novel multi-mechanistic therapeutic class for cancer","volume":"9","author":"Kirn","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nm.3089","article-title":"Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer","volume":"19","author":"Heo","year":"2013","journal-title":"Nat. Med."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Abou-Alfa, G.K., Galle, P.R., Chao, Y., Brown, K.T., Heo, J., Borad, M.J., Luca, A., Pelusio, A., Agathon, D., and Lusky, M. (2016). PHOCUS: A phase 3 randomized, open-label study comparing the oncolytic immunotherapy Pexa-Vec followed by sorafenib (SOR) vs SOR in patients with advanced hepatocellular carcinoma (HCC) without prior systemic therapy. J. Clin. Oncol., 34.","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS4146"},{"key":"ref_155","unstructured":"News., G. E. B. (2020, August 29). Pexa-Vec\/Nexavar Combination Fails Phase III Trial in Liver Cancer. Available online: https:\/\/www.genengnews.com\/news\/pexa-vec-nexavar-combination-fails-phase-iii-trial-in-liver-cancer\/."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Roderburg, C., \u00d6zdirik, B., Wree, A., Demir, M., and Tacke, F. (2020). Systemic treatment of hepatocellular carcinoma: From sorafenib to combination therapies. Hepatic Oncol., 7.","DOI":"10.2217\/hep-2020-0004"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of Mice and Not Men: Differences between Mouse and Human Immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus Ipilimumab in Advanced Melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Yau, T., Kang, Y.-K., Kim, T.-Y., El-Khoueiry, A.B., Santoro, A., Sangro, B., Melero, I., Kudo, M., Hou, M.-M., and Matilla, A. (2019). Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040. J. Clin. Oncol., 37.","DOI":"10.1200\/JCO.2019.37.15_suppl.4012"},{"key":"ref_161","first-page":"1536","article-title":"Trends in the treatment of advanced hepatocellular carcinoma: Immune checkpoint blockade immunotherapy and related combination therapies","volume":"9","author":"Cheng","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Wei, S., Sharma, R., Anang, N., Levine, J., Zhao, Y., Mancuso, J., Setty, M., Sharma, P., Wang, J., and Pe\u2019Er, D. (2019). Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States. immuneACCESS, 50.","DOI":"10.1016\/j.immuni.2019.03.004"},{"key":"ref_163","first-page":"181","article-title":"Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1\u2212CD8+ Tumor-Infiltrating T Cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41577-020-0275-8","article-title":"Dissecting the mechanisms of immune checkpoint therapy","volume":"20","author":"Sharma","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_165","first-page":"696","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"22699","DOI":"10.1073\/pnas.1821218116","article-title":"Combination anti\u2013CTLA-4 plus anti\u2013PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies","volume":"116","author":"Wei","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:16:55Z","timestamp":1760177815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/19\/7378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":166,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["ijms21197378"],"URL":"https:\/\/doi.org\/10.3390\/ijms21197378","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]}}}